Clinical Trial Update: A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease [Phase 2]

View source ↗

Summary

A Phase II randomized trial is comparing decidual stromal cells to the best available treatment for graft-versus-host disease. The study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Decidual stromal cells

Snippet

Sponsor: University Health Network, Toronto | Conditions: Graft Vs Host Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING